The present invention relates to a pharmaceutical composition for treatment and/or prevention of pancreatic cancer, which comprises Caprin-1 protein or a fragment thereof having 7 to 12 or more continuous amino acid residues, and an immunologically reactive antibody or a fragment thereof as active ingredients.